STOCK TITAN

[Form 4] Cadre Holdings, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Cadre Holdings, Inc. (CDRE) Form 4 filing: CEO, Chairman and 10% owner Warren B. Kanders reported the sale of 25,000 common shares on 06/23/2025. The transaction, coded “S”, was executed at a weighted-average price of $32.78 per share through the insider-controlled entity Kanders SAF, LLC.

Following the disposition, Kanders’ reported beneficial ownership stands at 10,216,192 shares indirectly via Kanders SAF, LLC, 45,584 shares held directly, 1,305,650 shares held in his Roth IRA, and 23,450 shares held in his spouse’s Roth IRA, for an aggregate of approximately 11.59 million shares. The sale thus represents roughly 0.22 % of his total reported holdings, leaving his ownership well above the 10 % threshold.

No derivative securities were reported, and the footnotes confirm that the reported price is weighted across multiple trades ranging $32.67-$32.96. Kanders remains the sole manager of Kanders SAF, LLC and disclaims beneficial ownership beyond his pecuniary interest.

Key takeaway: The filing shows a modest insider sale in dollar terms (~$0.8 million) relative to Kanders’ large strategic stake, with no indication of broader changes in ownership structure or corporate strategy.

Cadre Holdings, Inc. (CDRE) Comunicazione Form 4: Il CEO, Presidente e proprietario del 10% Warren B. Kanders ha segnalato la vendita di 25.000 azioni ordinarie il 23/06/2025. L'operazione, codificata come “S”, è stata effettuata a un prezzo medio ponderato di 32,78 $ per azione tramite l'entità controllata dall'insider Kanders SAF, LLC.

Dopo la vendita, la partecipazione beneficiaria segnalata da Kanders ammonta a 10.216.192 azioni indirettamente tramite Kanders SAF, LLC, 45.584 azioni detenute direttamente, 1.305.650 azioni nel suo Roth IRA e 23.450 azioni nel Roth IRA di sua moglie, per un totale di circa 11,59 milioni di azioni. La vendita rappresenta quindi circa il 0,22% delle sue partecipazioni totali dichiarate, mantenendo la sua proprietà ben al di sopra della soglia del 10%.

Non sono stati segnalati strumenti derivati, e le note a piè di pagina confermano che il prezzo riportato è una media ponderata di più operazioni tra 32,67 $ e 32,96 $. Kanders rimane l'unico amministratore di Kanders SAF, LLC e nega qualsiasi proprietà beneficiaria oltre il suo interesse pecuniario.

Conclusione principale: La comunicazione evidenzia una vendita interna modesta in termini di valore (~0,8 milioni di dollari) rispetto alla grande partecipazione strategica di Kanders, senza indicazioni di cambiamenti significativi nella struttura proprietaria o nella strategia aziendale.

Presentación Formulario 4 de Cadre Holdings, Inc. (CDRE): El CEO, presidente y propietario del 10% Warren B. Kanders reportó la venta de 25,000 acciones ordinarias el 23/06/2025. La transacción, codificada como “S”, se ejecutó a un precio promedio ponderado de $32.78 por acción a través de la entidad controlada por el insider Kanders SAF, LLC.

Después de la disposición, la propiedad beneficiaria reportada de Kanders es de 10,216,192 acciones indirectamente a través de Kanders SAF, LLC, 45,584 acciones en propiedad directa, 1,305,650 acciones en su Roth IRA y 23,450 acciones en el Roth IRA de su cónyuge, sumando un total aproximado de 11.59 millones de acciones. La venta representa aproximadamente el 0.22% de su total de participaciones reportadas, manteniendo su propiedad por encima del umbral del 10%.

No se reportaron valores derivados, y las notas aclaratorias confirman que el precio reportado es un promedio ponderado de múltiples operaciones entre $32.67 y $32.96. Kanders continúa siendo el único administrador de Kanders SAF, LLC y rechaza la propiedad beneficiaria más allá de su interés económico.

Conclusión clave: La presentación muestra una venta interna modesta en términos monetarios (~$0.8 millones) en relación con la gran participación estratégica de Kanders, sin indicios de cambios significativos en la estructura accionaria o la estrategia corporativa.

Cadre Holdings, Inc. (CDRE) Form 4 제출: CEO, 회장 및 10% 소유주인 Warren B. Kanders가 2025년 6월 23일에 25,000주 보통주 매도를 보고했습니다. 거래는 “S” 코드로 표시되었으며, 내부자가 관리하는 Kanders SAF, LLC를 통해 주당 가중평균 가격 $32.78에 실행되었습니다.

매도 후, Kanders의 보고된 실질 소유권은 Kanders SAF, LLC를 통한 간접 소유 10,216,192주, 직접 보유 45,584주, 본인의 Roth IRA에 1,305,650주, 배우자의 Roth IRA에 23,450주로 총 약 1,159만 주에 달합니다. 이번 매도는 전체 보유량의 약 0.22%에 해당하며, 소유 지분은 여전히 10% 기준선을 훨씬 상회합니다.

파생 증권은 보고되지 않았으며, 각주에 따르면 보고된 가격은 $32.67~$32.96 범위 내 여러 거래의 가중 평균임을 확인했습니다. Kanders는 Kanders SAF, LLC의 유일한 관리자이며 금전적 이익을 넘는 실질 소유권은 부인합니다.

주요 시사점: 제출 서류는 Kanders의 큰 전략적 지분에 비해 약 80만 달러 규모의 소규모 내부자 매도를 보여주며, 소유 구조나 기업 전략에 큰 변화는 없음을 나타냅니다.

Dépôt Formulaire 4 de Cadre Holdings, Inc. (CDRE) : Le PDG, président et détenteur de 10% Warren B. Kanders a déclaré la vente de 25 000 actions ordinaires le 23/06/2025. La transaction, codée « S », a été exécutée à un prix moyen pondéré de 32,78 $ par action via l’entité contrôlée par l’initié Kanders SAF, LLC.

Après cette cession, la propriété bénéficiaire déclarée de Kanders s’élève à 10 216 192 actions détenues indirectement via Kanders SAF, LLC, 45 584 actions détenues directement, 1 305 650 actions dans son Roth IRA et 23 450 actions dans le Roth IRA de son épouse, soit un total d’environ 11,59 millions d’actions. La vente représente donc environ 0,22 % de ses avoirs totaux déclarés, laissant sa participation bien au-dessus du seuil des 10 %.

Aucun titre dérivé n’a été signalé, et les notes de bas de page confirment que le prix déclaré est une moyenne pondérée de plusieurs transactions allant de 32,67 $ à 32,96 $. Kanders reste le seul gestionnaire de Kanders SAF, LLC et nie toute propriété bénéficiaire au-delà de son intérêt pécuniaire.

Conclusion clé : Le dépôt révèle une vente interne modérée en termes monétaires (~0,8 million de dollars) par rapport à la grande participation stratégique de Kanders, sans indication de changements majeurs dans la structure de propriété ou la stratégie d’entreprise.

Cadre Holdings, Inc. (CDRE) Form 4 Einreichung: CEO, Vorsitzender und 10%-Eigentümer Warren B. Kanders meldete den Verkauf von 25.000 Stammaktien am 23.06.2025. Die Transaktion, codiert als „S“, wurde zu einem gewichteten Durchschnittspreis von 32,78 $ pro Aktie über die insiderkontrollierte Einheit Kanders SAF, LLC ausgeführt.

Nach der Veräußerung beläuft sich Kanders’ gemeldetes wirtschaftliches Eigentum auf 10.216.192 Aktien indirekt über Kanders SAF, LLC, 45.584 direkt gehaltene Aktien, 1.305.650 Aktien in seinem Roth IRA und 23.450 Aktien im Roth IRA seiner Ehefrau, was insgesamt etwa 11,59 Millionen Aktien ergibt. Der Verkauf entspricht somit etwa 0,22 % seines insgesamt gemeldeten Bestands und lässt seinen Besitz deutlich über der 10%-Schwelle.

Es wurden keine Derivate gemeldet, und die Fußnoten bestätigen, dass der gemeldete Preis ein gewichteter Durchschnitt mehrerer Trades im Bereich von 32,67 $ bis 32,96 $ ist. Kanders bleibt der alleinige Geschäftsführer von Kanders SAF, LLC und weist wirtschaftliches Eigentum über sein finanzielles Interesse hinaus zurück.

Wichtigster Punkt: Die Einreichung zeigt einen moderaten Insider-Verkauf in Dollar-Beträgen (~0,8 Millionen $) im Verhältnis zu Kanders’ großem strategischen Anteil, ohne Anzeichen für größere Veränderungen in der Eigentümerstruktur oder Unternehmensstrategie.

Positive
  • None.
Negative
  • CEO/Chairman sold 25,000 shares (~$0.8 M), which could be interpreted as a mildly bearish insider signal.

Insights

TL;DR: Small sale (0.22%)—mostly neutral signal, ownership still >11 M shares.

The $0.82 million sale is immaterial compared with Warren Kanders’ 11.6 million-share stake. It does not materially change insider alignment or float dynamics. No derivatives or 10b5-1 plan disclosure is cited, but the limited size, continued >10 % ownership and absence of concurrent negative news suggest a neutral reading for investors. Liquidity impact should be negligible given CDRE’s average daily volume.

TL;DR: Routine Form 4, governance stance unchanged; watch for sale patterns.

Insider sales by controlling executives warrant monitoring, yet this filing shows a token disposal through an LLC vehicle. Kanders retains majority of his economic interest, preserving governance continuity. No red flags such as margin calls, derivative hedges, or multiple insiders selling concurrently are present. Unless the sale becomes part of a series, governance risk remains low.

Cadre Holdings, Inc. (CDRE) Comunicazione Form 4: Il CEO, Presidente e proprietario del 10% Warren B. Kanders ha segnalato la vendita di 25.000 azioni ordinarie il 23/06/2025. L'operazione, codificata come “S”, è stata effettuata a un prezzo medio ponderato di 32,78 $ per azione tramite l'entità controllata dall'insider Kanders SAF, LLC.

Dopo la vendita, la partecipazione beneficiaria segnalata da Kanders ammonta a 10.216.192 azioni indirettamente tramite Kanders SAF, LLC, 45.584 azioni detenute direttamente, 1.305.650 azioni nel suo Roth IRA e 23.450 azioni nel Roth IRA di sua moglie, per un totale di circa 11,59 milioni di azioni. La vendita rappresenta quindi circa il 0,22% delle sue partecipazioni totali dichiarate, mantenendo la sua proprietà ben al di sopra della soglia del 10%.

Non sono stati segnalati strumenti derivati, e le note a piè di pagina confermano che il prezzo riportato è una media ponderata di più operazioni tra 32,67 $ e 32,96 $. Kanders rimane l'unico amministratore di Kanders SAF, LLC e nega qualsiasi proprietà beneficiaria oltre il suo interesse pecuniario.

Conclusione principale: La comunicazione evidenzia una vendita interna modesta in termini di valore (~0,8 milioni di dollari) rispetto alla grande partecipazione strategica di Kanders, senza indicazioni di cambiamenti significativi nella struttura proprietaria o nella strategia aziendale.

Presentación Formulario 4 de Cadre Holdings, Inc. (CDRE): El CEO, presidente y propietario del 10% Warren B. Kanders reportó la venta de 25,000 acciones ordinarias el 23/06/2025. La transacción, codificada como “S”, se ejecutó a un precio promedio ponderado de $32.78 por acción a través de la entidad controlada por el insider Kanders SAF, LLC.

Después de la disposición, la propiedad beneficiaria reportada de Kanders es de 10,216,192 acciones indirectamente a través de Kanders SAF, LLC, 45,584 acciones en propiedad directa, 1,305,650 acciones en su Roth IRA y 23,450 acciones en el Roth IRA de su cónyuge, sumando un total aproximado de 11.59 millones de acciones. La venta representa aproximadamente el 0.22% de su total de participaciones reportadas, manteniendo su propiedad por encima del umbral del 10%.

No se reportaron valores derivados, y las notas aclaratorias confirman que el precio reportado es un promedio ponderado de múltiples operaciones entre $32.67 y $32.96. Kanders continúa siendo el único administrador de Kanders SAF, LLC y rechaza la propiedad beneficiaria más allá de su interés económico.

Conclusión clave: La presentación muestra una venta interna modesta en términos monetarios (~$0.8 millones) en relación con la gran participación estratégica de Kanders, sin indicios de cambios significativos en la estructura accionaria o la estrategia corporativa.

Cadre Holdings, Inc. (CDRE) Form 4 제출: CEO, 회장 및 10% 소유주인 Warren B. Kanders가 2025년 6월 23일에 25,000주 보통주 매도를 보고했습니다. 거래는 “S” 코드로 표시되었으며, 내부자가 관리하는 Kanders SAF, LLC를 통해 주당 가중평균 가격 $32.78에 실행되었습니다.

매도 후, Kanders의 보고된 실질 소유권은 Kanders SAF, LLC를 통한 간접 소유 10,216,192주, 직접 보유 45,584주, 본인의 Roth IRA에 1,305,650주, 배우자의 Roth IRA에 23,450주로 총 약 1,159만 주에 달합니다. 이번 매도는 전체 보유량의 약 0.22%에 해당하며, 소유 지분은 여전히 10% 기준선을 훨씬 상회합니다.

파생 증권은 보고되지 않았으며, 각주에 따르면 보고된 가격은 $32.67~$32.96 범위 내 여러 거래의 가중 평균임을 확인했습니다. Kanders는 Kanders SAF, LLC의 유일한 관리자이며 금전적 이익을 넘는 실질 소유권은 부인합니다.

주요 시사점: 제출 서류는 Kanders의 큰 전략적 지분에 비해 약 80만 달러 규모의 소규모 내부자 매도를 보여주며, 소유 구조나 기업 전략에 큰 변화는 없음을 나타냅니다.

Dépôt Formulaire 4 de Cadre Holdings, Inc. (CDRE) : Le PDG, président et détenteur de 10% Warren B. Kanders a déclaré la vente de 25 000 actions ordinaires le 23/06/2025. La transaction, codée « S », a été exécutée à un prix moyen pondéré de 32,78 $ par action via l’entité contrôlée par l’initié Kanders SAF, LLC.

Après cette cession, la propriété bénéficiaire déclarée de Kanders s’élève à 10 216 192 actions détenues indirectement via Kanders SAF, LLC, 45 584 actions détenues directement, 1 305 650 actions dans son Roth IRA et 23 450 actions dans le Roth IRA de son épouse, soit un total d’environ 11,59 millions d’actions. La vente représente donc environ 0,22 % de ses avoirs totaux déclarés, laissant sa participation bien au-dessus du seuil des 10 %.

Aucun titre dérivé n’a été signalé, et les notes de bas de page confirment que le prix déclaré est une moyenne pondérée de plusieurs transactions allant de 32,67 $ à 32,96 $. Kanders reste le seul gestionnaire de Kanders SAF, LLC et nie toute propriété bénéficiaire au-delà de son intérêt pécuniaire.

Conclusion clé : Le dépôt révèle une vente interne modérée en termes monétaires (~0,8 million de dollars) par rapport à la grande participation stratégique de Kanders, sans indication de changements majeurs dans la structure de propriété ou la stratégie d’entreprise.

Cadre Holdings, Inc. (CDRE) Form 4 Einreichung: CEO, Vorsitzender und 10%-Eigentümer Warren B. Kanders meldete den Verkauf von 25.000 Stammaktien am 23.06.2025. Die Transaktion, codiert als „S“, wurde zu einem gewichteten Durchschnittspreis von 32,78 $ pro Aktie über die insiderkontrollierte Einheit Kanders SAF, LLC ausgeführt.

Nach der Veräußerung beläuft sich Kanders’ gemeldetes wirtschaftliches Eigentum auf 10.216.192 Aktien indirekt über Kanders SAF, LLC, 45.584 direkt gehaltene Aktien, 1.305.650 Aktien in seinem Roth IRA und 23.450 Aktien im Roth IRA seiner Ehefrau, was insgesamt etwa 11,59 Millionen Aktien ergibt. Der Verkauf entspricht somit etwa 0,22 % seines insgesamt gemeldeten Bestands und lässt seinen Besitz deutlich über der 10%-Schwelle.

Es wurden keine Derivate gemeldet, und die Fußnoten bestätigen, dass der gemeldete Preis ein gewichteter Durchschnitt mehrerer Trades im Bereich von 32,67 $ bis 32,96 $ ist. Kanders bleibt der alleinige Geschäftsführer von Kanders SAF, LLC und weist wirtschaftliches Eigentum über sein finanzielles Interesse hinaus zurück.

Wichtigster Punkt: Die Einreichung zeigt einen moderaten Insider-Verkauf in Dollar-Beträgen (~0,8 Millionen $) im Verhältnis zu Kanders’ großem strategischen Anteil, ohne Anzeichen für größere Veränderungen in der Eigentümerstruktur oder Unternehmensstrategie.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KANDERS WARREN B

(Last) (First) (Middle)
C/O KANDERS & COMPANY, INC.
250 ROYAL PALM WAY, SUITE 201

(Street)
PALM BEACH FL 33480

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cadre Holdings, Inc. [ CDRE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
CEO AND CHAIRMAN
3. Date of Earliest Transaction (Month/Day/Year)
06/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.0001 per share ("Common Stock") 06/23/2025 S 25,000 D $32.78(1) 10,216,192 I By Kanders SAF, LLC(2)(4)
Common Stock 45,584 D
Common Stock 1,305,650 I By Warren B. Kanders Roth IRA
Common Stock 23,450 I By Allison Kanders Roth IRA(3)(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $32.67-$32.96 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
2. The Reporting Person is the sole manager and member of Kanders SAF, LLC.
3. Allison Kanders is the Reporting Person's spouse.
4. The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities.
/s/ Warren B. Kanders 06/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Cadre Holdings (CDRE) shares did Warren Kanders sell?

He sold 25,000 common shares on 06/23/2025.

At what price were the CDRE shares sold in this Form 4?

The weighted-average sale price was $32.78 per share, with trades between $32.67 and $32.96.

How many CDRE shares does Warren Kanders now own after the sale?

He beneficially owns approximately 11.59 million shares (direct and indirect combined).

Does Warren Kanders remain a 10% owner of Cadre Holdings after this transaction?

Yes. Despite the sale, his ownership is still well above the 10 % threshold.

Were any derivative securities involved in this CDRE Form 4 filing?

No derivative securities were reported; the filing concerns only common stock transactions.
Cadre Hldgs Inc

NYSE:CDRE

CDRE Rankings

CDRE Latest News

CDRE Latest SEC Filings

CDRE Stock Data

1.22B
28.22M
30.6%
69.35%
4.55%
Aerospace & Defense
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
JACKSONVILLE